H Dabachi*, AA Amar, S EL Youbi, H Naouli, H Jiber and A Bouarhoum

Vascular Surgery Department, Hassan II University Hospital, FES, Morocco

*Corresponding Author: H Dabachi, Vascular Surgery Department, Hassan II University Hospital, FES, Morocco.

Received: February 19, 2025; Published: February 26, 2025

Abstract

Vascular prosthesis infections require medical and surgical management. Probabilistic antibiotic therapy may be initiated before surgical treatment in the event of severe sepsis, septic shock or threat of septic mechanical complications (anastomotic detachment, aneurysmal rupture). It is based on a combination of a glycopeptide, a broad-spectrum beta-lactam and an aminoside. Once the caus ative bacteria(s) have been identified by blood cultures and/or intraoperative samples and the antibiogram data are known, specific antibiotic therapy with the narrowest possible spectrum will be prescribed for a total period of six weeks postoperatively. In the event of non-optimal surgical treatment, suppressive antibiotic therapy will be initiated following the usual antibiotic treatment [8].

Surgical management of aortic prosthesis infection includes excision of the prosthesis and revascularization of the lower limbs. The most commonly used material in France is cryopreserved arterial allograft or the use of femoral veins taken from the patient. These replacements with autogenous material allow in situ revascularization and have better resistance to infection. The other pos sibility of revascularization is extra-anatomical by axillo-bi-femoral bypass, especially used in cases of prosthetodigestive fistula [9].

The choice of medical-surgical treatment depends on the mode of contamination of the prosthesis, the incriminated germ, the location of the infected prosthesis and the general condition of the patient [8].

Keywords: Aortic Graft Infection; Duodenal Erosion; Gastrointestinal Hemorrhage; Aorto-Digestive Fistula; Medical-Surgical Treatment

References

1. Kieffer E., et al. “In-situ allograft replacement of infected infrarenal prosthetic grafts”. Journal of Vascular Surgery 17 (1993): 349-356.
2. Lorentzen JE., et al. “Vascular graft infection : an analysis of 62 graft infection in 2411 consecutively implanted synthetic vascular grafts”. Surgery 98 (1985): 81-86.
3. Calligaro KD and Veith FJ. “Diagnosis and management of infected prosthetic aortic grafts”. Surgery 110 (1991): 805-813.
4. Hayes PD., et al. “In-situ replacement of infected aortic graft with rifampicin-bonded prosthesis : the Leicester experience (1992 to 1998)”. Journal of Vascular Surgery 30 (1999): 92-98.
5. Mckeow PP and McDougall PP. “Diagnosis of arterial graft infection by indium-111 oxine white blood cell scans”. Circulation2 (1982): 1130-1134.
6. McDougall PP., et al. “Evaluation of 111In leukocyte whole body scanning”. AJR American Journal of Roentgenology 133 (1979): 849-854.
7. Szilagyi DE., et al. “Infection in arterial reconstruction with synthetic grafts”. Annals of Surgery 176 (1972): 321-333.
8. F Camou., et al. “Treatment of Prosthetic Vascular Graft Infections”. © SRLF et Lavoisier SAS (2016).
9. L Canaud., et al. “AlricTraitement chirurgical des infections des prothèses aortiques”. 11/01/17 [43-070].
10. Legout L., et al. “Risk factors for methicillin-resistant staphylococcal vascular graft infection in an 11-year cohort study”. Journal of Infectious 64 (2012): 441-442.
11. Vogt PR., et al. “Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques”. The Journal of Thoracic and Cardiovascular Surgery 116 (1998): 965-972.
12. Fiorani P., et al. “Long-term follow-up after in situ graft replacement in patients with aortofemoral graft infections”. European Journal of Vascular and Endovascular Surgery 14 (1997): 111-149.
13. Roy D and Grove DI. “Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts”. Journal of Infectious 40 (2000): 184-187.
14. Postier RG., et al. “Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients”. Clinical Therapy 26 (2004): 704-714.
15. Vogt PR., et al. “Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality”. Journal of Vascular Surgery 35 (2002): 80-86.
16. Revest M., et al. “Medical treatment of prosthetic vascular graft infections: review of the literature and proposals of a working group”. International Journal of Antimicrobial Agents 46 (2015): 254-256.
17. Aukema TS and Legemate DA. “Gluteopopliteal bypass for a compromised groin”. Journal of Vascular Surgery 49 (2009): 483-485.
18. Mertens RA., et al. “Surgical management of infrainguinal arterial prosthetic graft infections: review of a thirty-five-year experience”. Journal of Vascular Surgery 21 (1995): 782-790.
19. Murphy EH., et al. “The management of endograft infections following endovascular thoracic and abdominal aneurysm repair”. Journal of Vascular Surgery 58 (2013): 1179-1185.
20. Oderich GS., et al. “Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center”. Journal of Vascular Surgery 43 (2006): 1166-1174.
21. Jean-Baptiste E., et al. “Evaluation of the anti-infectious properties of polyester vascular prostheses functionalised with cyclodextrin”. Journal of Infectious 68 (2014): 116-124.
22. Topel I., et al. “Microbial spectrum and primary resistance to rifampicin in infectious complications in vascular surgery: limits to the use of rifampicin-bonded prosthetic grafts”. Angiology 61 (2010): 423-426.

Citation

Citation: H Dabachi., et al. “Aortic Prosthesis Infection on Duodenal Erosion: Case Report"Acta Scientific Paediatrics 8.2 (2025): 02-06.

Copyright

Copyright: © 2025 H Dabachi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.